PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19201082-5	2009	AMR-Me treatment resulted in suppression of hTERT expression and a concomitant inhibition of telomerase activity.	methyl 25-hydroxy-3-oxoolean-12-en-28-oate	0-6	telomerase reverse transcriptase	Homo sapiens	44-49	
19201082-8	2009	Our results suggest that AMR-Me inhibits telomerase activity by decreasing the hTERT expression and induces apoptosis in human lymphoblastic leukemic CEM cells, thus providing the molecular basis for the development of AMR-Me as a novel chemotherapeutic agent against leukemia.	methyl 25-hydroxy-3-oxoolean-12-en-28-oate	25-31	telomerase reverse transcriptase	Homo sapiens	79-84